Forward Citations = 1

Loading Chart...

4 inventors (with patents filed for the assignee):

Fengzhi Li (3 out of 8 patents)

Xiang Ling (3 out of 6 patents)

Qingyong Li (1 out of 1 patent)

4. Jianqun Liao (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 12268682 - Anticancer drug FL118 formulation for treatment of human cancer (2025-04-08),

2. 12187735 - Matter of composition, synthesis, formulation and application of FL118 platform positions 7 and 9-derived analogues for treatment of human disease (2025-01-07),

3. 10344037 - Use of the FL-one hundred eighteen core chemical structure platform to generate FL-one hundred eighteen derivatives for treatment of human disease (2019-07-09),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

3 Patents

#91 in Buffalo, NY

#4,516 in New York

#73,860 in US

Buffalo, NY, United States of America

Canget Biotek Pharma LLC

Forward Citations = 1

4 inventors:

Fengzhi Li (3 out of 8 patents)

Xiang Ling (3 out of 6 patents)

Qingyong Li (1 out of 1 patent)

4. Jianqun Liao (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Canget Biotek Pharma LLC. Retrieved from https://idiyas.com/company/canget-biotek-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]